In the last trading session, 3.6 million XORTX Therapeutics Inc (NASDAQ:XRTX) shares changed hands as the company’s beta touched 0.50. With the company’s per share price at $1.27 changed hands at $0.02 or 1.60% during last session, the market valuation stood at $4.42M. XRTX’s last price was a discount, traded about -451.18% off its 52-week high of $7.00. The share price had its 52-week low at $1.06, which suggests the last value was 16.54% up since then. When we look at XORTX Therapeutics Inc’s average trading volume, we note the 10-day average is 55560.0 shares, with the 3-month average coming to 56.80K.

XORTX Therapeutics Inc (NASDAQ:XRTX) trade information

Instantly XRTX was in green as seen at the end of in last trading. With action -3.05%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 12.43%, with the 5-day performance at -3.05% in the red. However, in the 30-day time frame, XORTX Therapeutics Inc (NASDAQ:XRTX) is 4.96% up. Looking at the short shares, we see there were 2238.0 shares sold at short interest cover period of 0.02 days.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 26.21%.

XRTX Dividends

XORTX Therapeutics Inc is expected to release its next quarterly earnings report in February.

XORTX Therapeutics Inc (NASDAQ:XRTX)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 3.02% of XORTX Therapeutics Inc shares while 6.03% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 6.22%.